Effect of chronic chloroquine administration on iron loading in the liver and reticuloendothelial system and on oxidative responses by the alveolar macrophages

Biochemical Pharmacology

Volumn 57, Issue 8, 1999, Pages 907-911

  Ward, Roberta J ^a   Crichton, Robert R ^a   Boelaert, Johan R ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b General Hospital St Jan   (Belgium)

Author keywords

Alveolar macrophages; Chloroquine; Iron depletion; Iron loading

Indexed keywords

CHLOROQUINE; IRON; IRON DEXTRAN; LIPOPOLYSACCHARIDE; NITRITE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; IRON DEFICIENCY; IRON OVERLOAD; LIVER; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RETICULOENDOTHELIAL SYSTEM; SPLEEN;

ANIMALS; CHLOROQUINE; IRON; LIPOPOLYSACCHARIDES; LIVER; MACROPHAGES, ALVEOLAR; MALE; NITRITES; OXIDATION-REDUCTION; RATS; RATS, WISTAR; RETICULOENDOTHELIAL SYSTEM; SUPEROXIDE DISMUTASE;

EID: 0033561572     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00368-2     Document Type: Article

References (36)

1. Hibbs J.B., Taintor R.R., Vavrin Z., Rachlin E.M. Nitric oxide A cytotoxic-activated macrophage effector molecule . Biochem Biophys Res Commun. 157:1989;87-96.
2. Jorens P.G., Boelaert J.R., Halloy V., Zamora R., Schneider Y-J., Herman A.G. Human and rat macrophages mediate fungistatic activity against Rhizopus species differently In vitro and ex vivo studies . Infect Immuni. 63:1995;4489-4494.
3. Zhang Y., Crichton R.R., Boelaert J.R., Jorens P.G., Herman A.G., Ward R.J., Lallemand F., De Witte P. Decreased release of nitric oxide NO by alveolar macrophages after in vivo loading of rats with either iron or ethanol. Biochem Pharmacol. 55:1998;21-25.
4. Jurado R.L. Iron, infections, and anaemia of inflammation. Clin Infect Dis. 25:1997;888-895.
5. Boelaert J.R., Piette J., Weinberg G.A., Sappey C., Weinberg E.D. Iron and oxidative stress as a mechanism for the enhanced production of human immunodeficiency virus by alveolar macrophages from otherwise healthy cigarette smokers. J Infect Dis. 173:1996;1045-1046.
6. Means R.T. Jr, Krantz S.B. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood. 80:1992;1639-1647.
7. Gordeuk V.R., McLaren G.D., Samowitz W. Etiologies, consequences, and treatment of iron overload. Crit Rev Clin Lab Sci. 31:1994;89-133.
8. Van Asbeck B.S., Marx J.J.M., Struyvenberg A., Verhoef J. Functional defects in phagocytic cells from patients with iron overload. J Infect Dis. 8:1984;232-240.
9. Aisen P., Listowsky I. Iron transport and storage proteins. Annu Rev Biochem. 49:1980;357-393.
10. de Duve C., de Barsy T., Poole B., Trouet A., Tulkens P., van Hoof F. Lysosomotropic agents. Biochem Pharmacol. 23:1974;2495-2531.
11. Ramm G.A., Powell L.W., Halliday J.W. Pathways of intracellular trafficking and release of ferritin by the liver in vivo: The effect of chloroquine and cytochalasin D. Hepatology. 19:1994;504-513.
12. Krogstad G.J., Schlesinger P.H. Acid-vesicle function, intracellular pathogens, and the action of chloroquine against Plasmodium falciparum. N Engl J Med. 317:1987;542-549.
13. Wellems T.E. Malaria. How chloroquine works. Nature. 355:1992;108-109.
14. Crichton R.R., Ward R.J. Iron metabolism Perspectives in view . Biochemistry. 31:1992;11255-11264.
15. Moss D., Fargion S., Fracanzani A.L., Levi S., Cappellini M.D., Arosio P., Powell L.W., Halliday J.W. Functional role of the ferritin receptors of human liver, hepatoma, lymphoid and erythroid cells. J Inorg Biochem. 47:1992;219-227.
16. Swainman K.F., Machen V.L. Chloroquine reduces neuronal and glial cell uptake. J Neurochem. 46:1986;652-654.
17. Kremsner P.G., Neifer S., Rasenack T., Bienzle U. Interference by antimalerial drugs with in vitro production of reactive nitrogen intermediates by murine macrophages. J Antimicrob Chemother. 31:1993;385-392.
18. Anstey N.N., Weinberg J.B., Hassanali M.Y., Mwaikambo E.D., Manyenga D., Misukonis M.A., Arnelle D.R., Hollis D., McDonald M.I., Granger D.L. Nitric oxide in Tanzanian children with maleria Inverse relationship between maleria severity and nitric oxide production/nitric oxide synthase type 2 expression . J Exp Med. 184:1996;557-567.
19. Ghigo D., Aldiere E., Todde R., Costamagna C., Garbarino G., Pescarmona G., Bosia A. Chloroquine stimulates nitric oxide synthase in murine, pocine and human endothelial cells. J Clin Invest. 102:1998;595-605.
20. Picot S., Peyron F., Donadille A., Vuillez J.P., Barbe G., Ambroise-Thomas P. Chloroquine-induced inhibition of the production of TNF, but not IL-6, is affected by disruption of iron metabolism. Immunology. 80:1993;127-133.
21. Sperber K., Quraishi H., Kalb T.H., Panja A., Stecher V., Mayer L. Selective regulation of cytokine secretion by hydroxychloroquine Inhibition of interleukin-1 alpha and IL-6 in human monocytes and T cells . J Rheumatol. 20:1993;803-808.
22. Pantopoulos K., Hentz M. Rapid responses to oxidative stress by iron regulatory protein. EMBO J. 14:1995;2917-2924.
23. Weiss G., Werner-Felmayer G., Werner E.R., Grunewald K., Wachter H., Hentze M.W. Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J Exp Med. 180:1994;969-976.
24. Weiss G and Dlaska M, Mechanism of iron-mediated regulation of iNOS expression. J Allergy Clin ImmunolS226, Abstract No. 939, 1998.
25. Boelaert J.R., Daneels R.F., Schurgers M.L., Matthys E.G., Gordts B.Z., Van-Landuyt H.W. Iron overload in haemodialysis patients increases the risk of bacteraemia A prospective study . Nephrol Dial Transplant. 5:1990;130-134.
26. Boelaert J.R. Iron and infection. Acta Clin Belg. 51:1996;213-221.
27. Weinberg E.D. Iron and Infection. Microbiol Rev. 42:1984;45.
28. Byrd T.F., Horwitz M.A. Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens. J Clin Invest. 88:1991;351-357.
29. Newman S.L., Gootee L., Brunner G., Deepe G.S. Jr. Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis. J Clin Invest. 93:1994;1422-1429.
30. Crowle A.J., May M.H. Inhibition of tubercle bacilli in cultured human macrophages by chloroquine used alone and in combination with streptomycin, isoniazid, pyrazinamide, and two metabolites of vitamin D3. Antimicrob Agents Chemother. 34:1990;2217-2222.
31. Mazzolla R., Barluzzi R., Brozzetti R., Boelaert J.R., Luna T., Saleppico S., Bistoni F., Blasi E. Enhanced resistance to Cryptococcus neoformans infection induced by chloroquine in a murine model of meningoencephalitis. Antimicrob Agents Chemother. 41:1997;802-807.
32. Levitz S.M., Harrison T.S., Tabuni A., Liu X. Chloroquine reduces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation. J Clin Invest. 100:1997;1640-1646.
33. Tsai W.P., Nara P.L., Kung H.F., Oroszlan S. Inhibition of human immunodeficiency virus infectivity by chloroquine. Aids Res Hum Retrov. 6:1990;481-489.
34. Sperber K., Kalb T.H., Stecher V.J., Banerjee R., Mayer L. Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes. Aids Res Hum Retrov. 9:1993;91-98.
35. Chiang G., Sassaroli M., Louie M., Chen H., Stecher V.J., Sperber K. Inhibition of HIV-1 replication by hydroxychloroquine Mechanism of action and comparison with zidovudine . Clin Ther. 18:1996;1080-1092.
36. Boelaert J.R., Weinberg G.A., Weinberg E.D. Altered iron metabolism in HIV infection Mechanisms, possible consequences, and proposals for management . Infect Agents Dis. 5:1996;36-46.